PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer

Published:2017-10 Issue: Volume:406 Page:27-35
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Shi Xiaojun,Zhang Xinji,Li Jinlong,Zhao Hongfan,Mo Lijun,Shi Xianghua,Hu Zhiming,Gao Jimin,Tan Wanlong^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2014

2. Immunotherapy of malignantgliomas using autologous and allogeneic tissue cells;Hofman;Anticancer Agents Med. Chem.,2010

3. Transient treg depletion enhances therapeutic anti-cancer vaccination;Fisher;Immun. Inflamm. Dis.,2016

4. A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity;Singh;Cancer Res.,2003

5. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors;Galanis;Crit. Rev. Oncol. Hematol.,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors;Current Cancer Drug Targets;2024-11

2. Approaches for boosting antitumor immunity in prostate cancer therapy: A comprehensive review on drugs, products, and nanoparticles;Journal of Drug Delivery Science and Technology;2023-11

3. Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2′-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors;Journal of Medicinal Chemistry;2023-07-26

4. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers;Frontiers in Immunology;2022-09-13

5. Development and validation of a prognostic model for esophageal carcinoma based on immune microenvironment using system bioinformatics;Cancer Medicine;2022-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3